|
1
|
Bai J, Hao J, Zhang X, Cui H, Han J and
Cao N: Netrin-1 attenuates the progression of renal dysfunction by
blocking endothelial-to-mesenchymal transition in the 5/6
nephrectomy rat model. BMC Nephrol. 17(47)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zeisberg M and Neilson EG: Mechanisms of
tubulointerstitial fibrosis. J Am Soc Nephrol. 21:1819–1834.
2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rostaing L and Kamar N: mTOR
inhibitor/proliferation signal inhibitors: Entering or leaving the
field? J Nephrol. 23:133–142. 2010.PubMed/NCBI
|
|
4
|
Deblon N, Bourgoin L, Veyrat-Durebex C,
Peyrou M, Vinciguerra M, Caillon A, Maeder C, Fournier M, Montet X,
Rohner-Jeanrenaud F and Foti M: Chronic mTOR inhibition by
rapamycin induces muscle insulin resistance despite weight loss in
rats. Br J Pharmacol. 165:2325–2340. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim D, Cheng GZ, Lindsley CW, Yang H and
Cheng JQ: Targeting the phosphatidylinositol-3 kinase/Akt pathway
for the treatment of cancer. Curr Opin Investig Drugs. 6:1250–1258.
2005.PubMed/NCBI
|
|
6
|
Takenaka T, Inoue T, Miyazaki T, Kobori H,
Nishiyama A, Ishii N, Hayashi M and Suzuki H: Klotho ameliorates
medullary fibrosis and pressure natriuresis in hypertensive rat
kidneys. Hypertension. 72:1151–1159. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen G, Chen H, Wang C, Peng Y, Sun L, Liu
H and Liu F: Rapamycin ameliorates kidney fibrosis by inhibiting
the activation of mTOR signaling in interstitial macrophages and
myofibroblasts. PLoS One. 7(e33626)2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Aboudehen K, Farahani S, Kanchwala M, Chan
SC, Avdulov S, Mickelson A, Lee D, Gearhart MD, Patel V, Xing C and
Igarashi P: Long noncoding RNA Hoxb3os is dysregulated in autosomal
dominant polycystic kidney disease and regulates mTOR signaling. J
Biol Chem. 293:9388–9398. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Raman A, Parnell SC, Zhang Y, Reif GA, Dai
Y, Khanna A, Daniel E, White C, Vivian JL and Wallace DP: Periostin
overexpression in collecting ducts accelerates renal cyst growth
and fibrosis in polycystic kidney disease. Am J Physiol Renal
Physiol. 315:F1695–F1707. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Peterson TR, Laplante M, Thoreen CC,
Sancak Y, Kang SA, Kuehl WM, Gray NS and Sabatini DM: DEPTOR is an
mTOR inhibitor frequently overexpressed in multiple myeloma cells
and required for their survival. Cell. 137:873–886. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bruneau S, Nakayama H, Woda CB, Flynn EA
and Briscoe DM: DEPTOR regulates vascular endothelial cell
activation and proinflammatory and angiogenic responses. Blood.
122:1833–1842. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Das F, Ghosh-Choudhury N, Bera A, Dey N,
Abboud HE, Kasinath BS and Choudhury GG: Transforming growth factor
β integrates Smad 3 to mechanistic target of rapamycin complexes to
arrest deptor abundance for glomerular mesangial cell hypertrophy.
J Biol Chem. 288:7756–7768. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Das F, Ghosh-Choudhury N, Lee DY, Gorin Y,
Kasinath BS and Choudhury GG: Akt2 causes TGFβ-induced deptor
downregulation facilitating mTOR to drive podocyte hypertrophy and
matrix protein expression. PLoS One. 13(e0207285)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Maity S, Bera A, Ghosh-Choudhury N, Das F,
Kasinath BS and Choudhury GG: microRNA-181a downregulates deptor
for TGFβ-induced glomerular mesangial cell hypertrophy and matrix
protein expression. Exp Cell Res. 364:5–15. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Das F, Bera A, Ghosh-Choudhury N, Abboud
HE, Kasinath BS and Choudhury GG: TGFβ-induced deptor suppression
recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene
expression. PLoS One. 9(e109608)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang C, Dai H, Xiong Z, Song Q, Zou Z, Li
M, Nie J, Bai X and Chen Z: Loss of DEPTOR in renal tubules
protects against cisplatin-induced acute kidney injury. Cell Death
Dis. 9(441)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Obara A, Fujita Y, Abudukadier A,
Fukushima T, Oguri Y, Ogura M, Harashima S, Hosokawa M and Inagaki
N: DEPTOR-related mTOR suppression is involved in metformin's
anti-cancer action in human liver cancer cells. Biochem Biophys Res
Commun. 460:1047–1052. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cavaglieri RC, Day RT, Feliers D and
Abboud HE: Metformin prevents renal interstitial fibrosis in mice
with unilateral ureteral obstruction. Mol Cell Endocrinol.
412:116–122. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Oda SS: Metformin protects against
experimental acrylamide neuropathy in rats. Drug Dev Res.
78:349–359. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Montinaro V, Hevey K, Aventaggiato L,
Fadden K, Esparza A, Chen A, Finbloom DS and Rifai A: Extrarenal
cytokines modulate the glomerular response to IgA immune complexes.
Kidney Int. 42:341–353. 1992.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sun D, Liu CX, Ma YY and Zhang L:
Protective effect of prostaglandin E1 on renal microvascular injury
in rats of acute aristolochic acid nephropathy. Ren Fail.
33:225–232. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen YJ, Kong L, Tang ZZ, Zhang YM, Liu Y,
Wang TY and Liu YW: Hesperetin ameliorates diabetic nephropathy in
rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomed
Pharmacother. 111:1166–1175. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xia A, Xue Z, Li Y, Wang W, Xia J, Wei T,
Cao J and Zhou W: Cardioprotective effect of betulinic Acid on
myocardial ischemia reperfusion injury in rats. Evid Based
Complement Alternat Med. 2014(573745)2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Caron A, Baraboi ED, Laplante M and
Richard D: DEP domain-containing mTOR-interacting protein in the
rat brain: Distribution of expression and potential implication. J
Comp Neurol. 523:93–107. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Davies J, Zachariades E, Rogers-Broadway
KR and Karteris E: Elucidating the role of DEPTOR in Alzheimer's
disease. Int J Mol Med. 34:1195–1200. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang CP, Lorenzo C, Habib SL, Jo B and
Espinoza SE: Differential effects of metformin on age related
comorbidities in older men with type 2 diabetes. J Diabetes
Complications. 31:679–686. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kita Y, Takamura T, Misu H, Ota T, Kurita
S, Takeshita Y, Uno M, Matsuzawa-Nagata N, Kato K, Ando H, et al:
Metformin prevents and reverses inflammation in a non-diabetic
mouse model of nonalcoholic steatohepatitis. PLoS One.
7(e43056)2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Guiteras R, Flaquer M and Cruzado JM:
Macrophage in chronic kidney disease. Clin Kidney J. 9:765–771.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Meng XM, Wang S, Huang XR, Yang C, Xiao J,
Zhang Y, To KF, Nikolic-Paterson DJ and Lan HY: Inflammatory
macrophages can transdifferentiate into myofibroblasts during renal
fibrosis. Cell Death Dis. 7(e2495)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kapoor V, Zaharieva MM, Das SN and Berger
MR: Erufosine simultaneously induces apoptosis and autophagy by
modulating the Akt-mTOR signaling pathway in oral squamous cell
carcinoma. Cancer Lett. 319:39–48. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Krause U, Bertrand L and Hue L: Control of
p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by
AMP-activated protein kinase and protein phosphatases in isolated
hepatocytes. Eur J Biochem. 269:3751–3759. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yang Y, Wang J, Qin L, Shou Z, Zhao J,
Wang H, Chen Y and Chen J: Rapamycin prevents early steps of the
development of diabetic nephropathy in rats. Am J Nephrol.
27:495–502. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH
and Tang MJ: Rapamycin attenuates unilateral ureteral
obstruction-induced renal fibrosis. Kidney Int. 69:2029–2036.
2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Feng J, Li H, Zhang Y, Wang Q, Zhao S,
Meng P and Li J: Mammalian STE20-like kinase 1 deletion alleviates
renal ischaemia-reperfusion injury via modulating mitophagy and the
AMPK-YAP signalling pathway. Cell Physiol Biochem. 51:2359–2376.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhou X, Muise ES, Haimbach R, Sebhat IK,
Zhu Y, Liu F, Souza SC, Kan Y, Pinto S, Kelley DE and Hoek M:
PAN-AMPK activation improves renal function in a rat model of
progressive diabetic nephropathy. J Pharmacol Exp Ther. 371:45–55.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Brynildsen JK, Lee BG, Perron IJ, Jin S,
Kim SF and Blendy JA: Activation of AMPK by metformin improves
withdrawal signs precipitated by nicotine withdrawal. Proc Natl
Acad Sci USA. 115:4282–4287. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Viana R, Aguado C, Esteban I, Moreno D,
Viollet B, Knecht E and Sanz P: Role of AMP-activated protein
kinase in autophagy and proteasome function. Biochem Biophys Res
Commun. 369:964–968. 2008.PubMed/NCBI View Article : Google Scholar
|
